KATHY ATTIG: Open Payments
NPI 1023765575 · YORK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$784 in 23 payments from 12 companies in 2025. Trend: 2023 $1,058 · 2024 $981 · 2025 $784
Food & beverage: $784
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 8 | $177 |
| BridgeBio Pharma, Inc. | 1 | $121 |
| Kestra Medical Technology Services, Inc. | 1 | $119 |
| Impulse Dynamics (USA) Inc. | 2 | $117 |
| SCPHARMACEUTICALS INC. | 2 | $46 |
| Novo Nordisk Inc | 2 | $44 |
| ABIOMED | 1 | $40 |
| PFIZER INC. | 2 | $35 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Abbott Laboratories | 1 | $21 |
Products named: FARAPULSE, Attruby, Assure WCD, Optimizer, FUROSCIX, VYNDAQEL, Wegovy, VERQUVO.
Industry payments across PA — which companies pay providers there.
